今日观察！A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.

iPhone直播间数字商品“消失”：苹果与电商平台博弈加剧？

北京，2024年6月14日 - 据多位网友反映，在刚刚结束的618电商大促期间，他们发现一些品牌的iPhone手机在抖音、快手等平台的直播间内，无法直接购买数字商品，例如爱奇艺、优酷等视频平台的会员。

有分析称，这可能是由于苹果与电商平台未能就“苹果税”达成一致，导致相关商品链接被下架。

“苹果税”争议再起

苹果公司一直对在其应用商店（App Store）内销售的数字商品收取30%的佣金，被称为“苹果税”。这一政策引发了众多开发者的不满，他们认为苹果收取的佣金过高，侵犯了他们的利益。

近年来，中国监管部门也开始关注“苹果税”问题，并采取措施加强对互联网平台的监管。今年5月，国家市场监督管理总局发布了《反垄断规定》，其中明确禁止平台利用市场支配地位限定交易价格、强制交易等行为。

电商平台积极寻求突破

为了降低“苹果税”的影响，一些电商平台开始积极寻求突破。例如，京东允许用户在直播间内直接购买爱奇艺、优酷等视频平台的会员，并提供折扣优惠。

此外，还有电商平台开始探索新的销售模式，例如拼多多推出了“多多买菜”小程序，允许用户在小程序内直接购买商品，无需跳转到App Store。

苹果如何应对？

面对电商平台的挑战，苹果也采取了一些措施来应对。例如，苹果推出了“App Store订阅服务”，允许开发者提供订阅服务，并降低了订阅服务的佣金。

不过，苹果的这些措施似乎并未奏效。从618期间的情况来看，苹果与电商平台在“苹果税”问题上的博弈仍在加剧。

未来走向

“苹果税”问题未来如何发展，仍有待观察。如果中国监管部门进一步加强对互联网平台的监管，苹果可能会被迫降低“苹果税”的比例。

不过，苹果也可能会采取其他措施来维护其在App Store市场的垄断地位。例如，苹果可能会限制电商平台在App Store内推广其直播业务。

以下是一些关于“苹果税”问题的额外信息：

• 欧盟委员会也在调查苹果的“苹果税”政策，并有可能对苹果处以巨额罚款。
• 一些分析人士认为，苹果可能会在未来推出自己的视频流媒体服务，以进一步扩大其在数字服务领域的收入。

请注意：

• 本新闻稿仅供参考，不构成任何投资建议。
• 本新闻稿中的信息可能存在误差或遗漏，恕不承担任何责任。